JP2001521497A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001521497A5 JP2001521497A5 JP1998541168A JP54116898A JP2001521497A5 JP 2001521497 A5 JP2001521497 A5 JP 2001521497A5 JP 1998541168 A JP1998541168 A JP 1998541168A JP 54116898 A JP54116898 A JP 54116898A JP 2001521497 A5 JP2001521497 A5 JP 2001521497A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200881.7 | 1997-03-27 | ||
| EP97200881 | 1997-03-27 | ||
| EP97202785.8 | 1997-09-11 | ||
| EP97202785 | 1997-09-11 | ||
| PCT/EP1998/001920 WO1998043646A1 (en) | 1997-03-27 | 1998-03-25 | New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009168383A Division JP5023315B2 (ja) | 1997-03-27 | 2009-07-17 | 精神異常症の治療または予防処置のための、ミルタザピンと抗精神病剤の新規組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001521497A JP2001521497A (ja) | 2001-11-06 |
| JP2001521497A5 true JP2001521497A5 (enExample) | 2005-11-10 |
| JP4377456B2 JP4377456B2 (ja) | 2009-12-02 |
Family
ID=26146283
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54116898A Expired - Fee Related JP4377456B2 (ja) | 1997-03-27 | 1998-03-25 | 精神異常症を治療及び／又は予防するための組成物 |
| JP2009168383A Expired - Fee Related JP5023315B2 (ja) | 1997-03-27 | 2009-07-17 | 精神異常症の治療または予防処置のための、ミルタザピンと抗精神病剤の新規組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009168383A Expired - Fee Related JP5023315B2 (ja) | 1997-03-27 | 2009-07-17 | 精神異常症の治療または予防処置のための、ミルタザピンと抗精神病剤の新規組み合わせ |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0969845B1 (enExample) |
| JP (2) | JP4377456B2 (enExample) |
| KR (1) | KR100577865B1 (enExample) |
| CN (1) | CN1226036C (enExample) |
| AR (1) | AR012193A1 (enExample) |
| AT (1) | ATE318604T1 (enExample) |
| AU (1) | AU726194B2 (enExample) |
| BR (1) | BR9808077A (enExample) |
| CA (1) | CA2284551C (enExample) |
| CZ (1) | CZ298105B6 (enExample) |
| DE (1) | DE69833645T2 (enExample) |
| DK (1) | DK0969845T3 (enExample) |
| ES (1) | ES2259207T3 (enExample) |
| HU (1) | HUP0002742A3 (enExample) |
| ID (1) | ID22283A (enExample) |
| IL (1) | IL123716A (enExample) |
| NO (1) | NO994673L (enExample) |
| NZ (1) | NZ337618A (enExample) |
| PL (1) | PL191449B1 (enExample) |
| PT (1) | PT969845E (enExample) |
| RU (1) | RU2222330C2 (enExample) |
| TR (1) | TR199902334T2 (enExample) |
| TW (1) | TW587938B (enExample) |
| WO (1) | WO1998043646A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| US6280763B1 (en) | 1999-05-10 | 2001-08-28 | Pierce Management, Llc | Apparatus and method for transdermal delivery of bupropion |
| FR2797399B1 (fr) * | 1999-08-13 | 2002-10-18 | Aventis Pharma Sa | Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines |
| FR2802101B1 (fr) | 1999-12-10 | 2003-02-28 | Aventis Pharma Sa | Association de cymemazine et d'un neuroleptique atypique |
| US6350773B1 (en) | 1999-12-10 | 2002-02-26 | American Home Products Corporation | Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders |
| EP1251854A2 (en) | 2000-01-19 | 2002-10-30 | Akzo Nobel N.V. | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| US6495154B1 (en) * | 2000-11-21 | 2002-12-17 | Vivus Inc. | On demand administration of clomipramine and salts thereof to treat premature ejaculation |
| EP1795199A3 (en) * | 2001-02-06 | 2007-07-25 | AstraZeneca AB | Quetiapine for the treatment of substance dependence or substance abuse |
| DE60219761T2 (de) * | 2001-02-06 | 2008-01-17 | Astrazeneca Ab | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit |
| RU2232574C2 (ru) * | 2002-04-05 | 2004-07-20 | Новосибирский институт органической химии им. Н.Н.Ворожцова СО РАН | Лекарственное средство для лечения различных форм депрессий "флуоглизин" |
| JP5547865B2 (ja) | 2003-10-29 | 2014-07-16 | ワイス・エルエルシー | アプリンドルおよびその誘導体を含む持続放出型医薬組成物 |
| US7884096B2 (en) | 2003-12-02 | 2011-02-08 | Pharmaneuroboost N.V. | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| DK1541197T3 (da) * | 2003-12-02 | 2009-06-15 | Pharmaneuroboost N V | Anvendelse af pipamperon og en SNDRI, SNRI eller SSRI til behandling af humörsvingninger eller angstlidelser |
| EP1547650A1 (en) * | 2003-12-02 | 2005-06-29 | B & B Beheer NV | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| US8304431B2 (en) | 2003-12-02 | 2012-11-06 | Pharmaneuroboost N.V. | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| US7855195B2 (en) | 2003-12-02 | 2010-12-21 | Pharmaneuroboost N.V. | Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| WO2005117916A1 (en) | 2004-06-03 | 2005-12-15 | F. Hoffmann-La Roche Ag | Treatment with cisplatin and an egfr-inhibitor |
| CA2653827C (en) * | 2006-06-09 | 2014-04-08 | Dainippon Sumitomo Pharma Co., Ltd. | Novel blonanserin tape preparation |
| TWI636784B (zh) * | 2011-04-05 | 2018-10-01 | 大塚製藥股份有限公司 | 含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途 |
| DE102012011839B4 (de) * | 2012-06-14 | 2018-03-22 | Norbert Müller | Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen |
| RU2509560C1 (ru) * | 2013-03-22 | 2014-03-20 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2410821A1 (de) * | 1974-03-07 | 1975-09-18 | Hoechst Ag | Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung |
| CA1327008C (en) * | 1988-01-15 | 1994-02-15 | Walter Merz | Anti-psychotic imidazobenzodiazepine |
| ES2062310T3 (es) * | 1989-12-06 | 1994-12-16 | Akzo Nv | Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado. |
| NZ241481A (en) * | 1991-02-04 | 1994-06-27 | Hoechst Roussel Pharma | Derivatives of 8-aza-bicyclo[3.2.1]octane and pharmaceutical compositions thereof |
| ZA935078B (en) * | 1992-07-15 | 1994-02-07 | Nicolaas Johannes Jaco Loetter | Pharmaceutical composition |
| RU2062114C1 (ru) * | 1992-09-30 | 1996-06-20 | Московский научно-исследовательский институт психиатрии МЗ РФ | Способ лечения эндогенных психозов |
| EP0669128B1 (en) * | 1992-11-17 | 2000-01-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release microsphere containing antipsychotic and process for producing the same |
| JPH07242669A (ja) * | 1994-03-07 | 1995-09-19 | Akikazu Ogawa | 四環系とブチロフェノン誘導体を化学結合した化合物 |
-
1998
- 1998-03-17 TW TW087103929A patent/TW587938B/zh not_active IP Right Cessation
- 1998-03-17 IL IL12371698A patent/IL123716A/xx not_active IP Right Cessation
- 1998-03-25 CZ CZ0343199A patent/CZ298105B6/cs not_active IP Right Cessation
- 1998-03-25 DK DK98919209T patent/DK0969845T3/da active
- 1998-03-25 HU HU0002742A patent/HUP0002742A3/hu unknown
- 1998-03-25 RU RU99122597/14A patent/RU2222330C2/ru not_active IP Right Cessation
- 1998-03-25 CN CNB98803770XA patent/CN1226036C/zh not_active Expired - Fee Related
- 1998-03-25 NZ NZ337618A patent/NZ337618A/en unknown
- 1998-03-25 WO PCT/EP1998/001920 patent/WO1998043646A1/en not_active Ceased
- 1998-03-25 ES ES98919209T patent/ES2259207T3/es not_active Expired - Lifetime
- 1998-03-25 TR TR1999/02334T patent/TR199902334T2/xx unknown
- 1998-03-25 PT PT98919209T patent/PT969845E/pt unknown
- 1998-03-25 ID IDW991022A patent/ID22283A/id unknown
- 1998-03-25 CA CA002284551A patent/CA2284551C/en not_active Expired - Fee Related
- 1998-03-25 KR KR1019997008745A patent/KR100577865B1/ko not_active Expired - Fee Related
- 1998-03-25 AT AT98919209T patent/ATE318604T1/de not_active IP Right Cessation
- 1998-03-25 DE DE69833645T patent/DE69833645T2/de not_active Expired - Lifetime
- 1998-03-25 EP EP98919209A patent/EP0969845B1/en not_active Expired - Lifetime
- 1998-03-25 BR BR9808077-6A patent/BR9808077A/pt not_active Application Discontinuation
- 1998-03-25 JP JP54116898A patent/JP4377456B2/ja not_active Expired - Fee Related
- 1998-03-25 AU AU72139/98A patent/AU726194B2/en not_active Ceased
- 1998-03-25 PL PL335890A patent/PL191449B1/pl unknown
- 1998-03-27 AR ARP980101406A patent/AR012193A1/es not_active Application Discontinuation
-
1999
- 1999-09-24 NO NO19994673A patent/NO994673L/no not_active Application Discontinuation
-
2009
- 2009-07-17 JP JP2009168383A patent/JP5023315B2/ja not_active Expired - Fee Related